High glucose levels, also called hyperglycemia, can occur when the body has too little insulin or cannot use insulin effectively. Food, illness, stress hormones, medications, and hormone changes can also raise a reading for a short time. One high result does not always mean diabetes, but repeated highs or symptoms deserve clinical follow-up 1 3.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does a high glucose level mean?
A high glucose level means there is more glucose, the body’s main fuel source, circulating in the blood than expected. Blood glucose changes through the day, especially after meals, while A1C estimates average glucose exposure over roughly 2 to 3 months 1.
Blood glucose vs A1C: what each test measures
Fasting plasma glucose is measured after not eating for at least 8 hours. Post-meal glucose shows how the body handles food. Hemoglobin A1C, often shortened to A1C, reflects how much glucose has attached to red blood cells over their lifespan. Clinicians may use more than one test because anemia, pregnancy, kidney disease, and some blood conditions can make A1C less reliable 1.
Why one high reading is different from repeated high readings
A high result after a large meal, during an infection, or after a medication change may not reflect a long-term problem. In people without classic symptoms of high glucose, diabetes testing is generally confirmed with repeat abnormal results or a second test 1. For more detail on interpreting a lab result, see our guide to high glucose in a blood test.
Quick facts: common causes, symptoms, and when to ask for help
Persistent high glucose can be related to prediabetes, type 1 diabetes, type 2 diabetes, or another medical issue. Thirst, frequent urination, fatigue, blurry vision, recurrent infections, and unexplained weight loss are reasons to contact a clinician, especially when they occur with repeated high readings 3.
What are the most common causes of high glucose levels?
The most common causes are reduced insulin production, reduced insulin response, and temporary changes in hormones or metabolism. Insulin resistance is especially common before and during type 2 diabetes, but the correct explanation depends on the person’s symptoms, tests, medicines, and health history 1.
Diabetes and not enough insulin action
Insulin helps move glucose from the bloodstream into cells. In type 1 diabetes, the body makes little or no insulin. In type 2 diabetes, cells become less responsive to insulin and the pancreas may gradually struggle to keep up. Both can lead to hyperglycemia, though the testing and treatment approach differs 1.
Insulin resistance and weight-related metabolic changes
Insulin resistance means muscle, fat, and liver cells do not respond normally to insulin. The pancreas may initially make more insulin to compensate, so glucose can remain normal for a time. Prediabetes can develop when that compensation is no longer enough 1. Our overview of how to know if you have insulin resistance explains common tests and limits of symptom-based self-checks.
Food, illness, stress, and hormones
Carbohydrate amount and timing can affect post-meal glucose. Acute illness, pain, poor sleep, and emotional stress can also increase stress hormones such as cortisol and glucagon, which signal the liver to release glucose. Puberty, menstruation, pregnancy, and competitive sports or heavy weightlifting can shift glucose patterns as well 3.
Medications that can raise glucose
Glucocorticoids, often called steroids, are a well-known cause of medication-related hyperglycemia 3. Some other medicines can affect glucose in certain people. Statins are important medicines for cardiovascular risk reduction, but a randomized study found changes in glycemic measures in some participants taking statins alongside diabetes medicines; do not stop a prescribed statin without discussing the trade-offs with the prescriber 7.
Can glucose be high without diabetes?
Yes. Temporary hyperglycemia can occur during infection, major stress, surgery, steroid use, or other short-term physical stress. Still, a temporary trigger does not rule out prediabetes or diabetes, so repeat testing may be appropriate when results remain high 1 3.
A clinician may consider fasting plasma glucose, A1C, or an oral glucose tolerance test based on when the high reading happened and a person’s risk factors. Pregnancy needs prompt, pregnancy-specific evaluation because testing and glucose goals are different 1.
| Situation | What may be going on | Sensible next step |
|---|---|---|
| One high result during illness or after a steroid change | A temporary stress or medication effect may be contributing | Tell the prescribing clinician and ask whether repeat testing is needed 1. |
| Repeated high fasting readings or elevated A1C | Prediabetes, diabetes, or another metabolic issue may need evaluation | Arrange a clinical visit for confirmatory testing and a personal plan 1. |
| High readings after meals but normal fasting results | Meal timing, carbohydrate amount, or early impaired glucose handling may be relevant | Review the pattern with a clinician; a meter or CGM may sometimes help 10. |
| Known diabetes with rising readings | Medication, illness, insulin delivery, or food-pattern changes may be involved | Follow the person’s existing diabetes plan and contact their diabetes team 2. |
| High glucose with vomiting, confusion, or deep breathing | Diabetic ketoacidosis or another serious illness is possible | Seek urgent emergency care 2. |
What symptoms can high glucose cause?
High glucose may cause no symptoms at first. When symptoms occur, thirst and frequent urination are common because the kidneys try to remove extra glucose through urine 3.
Other symptoms can include fatigue, trouble concentrating, blurred vision, recurrent yeast or other infections, slow-healing cuts, and unexplained weight loss. Symptoms alone cannot identify the cause, so they should be paired with appropriate testing 3.
How do clinicians figure out why glucose is high?
Clinicians look for a pattern rather than relying on one number. Timing matters: a fasting result, a post-meal result, a reading during illness, and a result after starting a medicine can mean different things 1.
Testing may include repeat fasting glucose, A1C, or an oral glucose tolerance test. For people with symptoms of severe insulin deficiency or very high glucose, clinicians may also check blood or urine ketones 1 2.
How CGMs and fingerstick meters can help show patterns
A continuous glucose monitor, or CGM, measures glucose in fluid just under the skin over time. Fingerstick meters give point-in-time readings. Either tool can help show how food, activity, medication, and daily routines relate to glucose, but home readings do not replace diagnostic testing 10.
Safe blood glucose monitoring
Do not share fingerstick lancing devices. Shared monitoring equipment can spread bloodborne infections; FDA and CDC guidance recommends using devices for one person whenever possible and cleaning meters as directed when sharing cannot be avoided 9.
3-min quiz
Talk through persistent high glucose with a licensed provider
If weight, insulin resistance, or metabolic health is part of your concern, Chia offers a clinician-reviewed online path for eligible adults. A prescription requires a medical evaluation and is not guaranteed. Our providers can discuss compounded semaglutide injection or compounded tirzepatide tablets and injections only when clinically appropriate. Medications are compounded by US state-licensed 503A pharmacies and shipped to your door. Compounded drugs are not FDA-approved 11.
What helps lower high glucose safely?
What helps depends on the cause. Individualized glucose targets are safer than trying to lower every number as quickly as possible, particularly for people using insulin or medicines that can cause low glucose 6.
Lifestyle foundations come first
For many people, clinicians start with a sustainable food pattern, regular physical activity, sleep, and weight management when appropriate. These steps can support insulin sensitivity and overall cardiometabolic health, but they do not replace insulin or other prescribed diabetes treatment when the body needs it 1 2.
Medication review and individualized care
A clinician should review medicines that may raise glucose, plus medicines used to lower it. In the ACCORD trial of adults with type 2 diabetes at high cardiovascular risk, intensive glucose lowering was associated with increased mortality, underscoring why glucose goals and treatment intensity should be individualized rather than pushed aggressively for everyone 6.
For people with diabetes, medication-related low blood sugar is also a real risk. Insulin and sulfonylureas can cause hypoglycemia, and risk can change with food intake, activity, kidney function, and other medicines 4 5.
How can high glucose, insulin resistance, and weight care fit together at Chia?
For some adults, excess weight and insulin resistance are connected and weight management may be one part of a broader metabolic plan. Chia does not diagnose diabetes through this article, and people with repeated high glucose, known diabetes, pregnancy, or glucose-lowering medicines need an individualized clinician evaluation 1.
At Chia, eligible patients can be evaluated online for semaglutide, a GLP-1 receptor agonist active ingredient, or tirzepatide, a dual GIP/GLP-1 receptor agonist active ingredient 4 5. Wegovy is an FDA-approved semaglutide brand product for chronic weight management, and Mounjaro is an FDA-approved tirzepatide brand product for type 2 diabetes 4 5. Chia offers compounded formulations, not generic or equivalent versions of those brands; compounded formulations are not FDA-approved 11.
FDA-approved semaglutide and tirzepatide products have labeled uses that vary by product, including chronic weight management or type 2 diabetes. Their labels also warn about gastrointestinal side effects, pancreatitis risk, gallbladder disease, and hypoglycemia risk when used with insulin or insulin secretagogues; they are not appropriate for everyone 4 5. Results for compounded formulations are not established by FDA-evaluated outcomes data 11.
| Chia option | Available form at Chia | How the care path works |
|---|---|---|
| Compounded semaglutide | Injection; plans currently start at $249/month | A licensed US provider reviews an online questionnaire and may prescribe if clinically appropriate. Microdosing plans are available when clinically appropriate. |
| Compounded tirzepatide | Tablets from $249/month or injection from $299/month | A licensed US provider reviews an online questionnaire and may prescribe if clinically appropriate. Microdosing plans are available when clinically appropriate. |
| Weight + Energy protocol | NAD+ injection plus a choice of GLP-1; plans currently start at $309/month | This is a multi-treatment protocol that requires provider review. The compounded medications in this protocol are not FDA-approved, and FDA has not evaluated this protocol for safety, effectiveness, or any specific indication 11. See the Weight + Energy protocol for current details. |
Our care is 100% online: a short health questionnaire is reviewed by a licensed US provider, who prescribes only where clinically appropriate. Prescriptions are never guaranteed. When prescribed, medications are compounded in the US by state-licensed 503A compounding pharmacies, delivered to the patient’s door, and dosing is provider-guided over time. Compounded drugs are not FDA-approved 11.
What questions should you ask your clinician about high glucose?
Bring the actual number, the test type, when you last ate, current medicines, and any symptoms. A clear timeline often helps a clinician decide whether the result may be temporary or needs further testing 1.
- Could this result fit diabetes, prediabetes, insulin resistance, illness-related hyperglycemia, or a medication effect?
- Should I repeat fasting glucose, A1C, or another test?
- What glucose and A1C targets fit my health history and medicines?
- Would home monitoring or a CGM add useful information for me?
- Could changes in weight, sleep, activity, or medication affect my plan?
- If weight-management medicine is being considered, how would it affect my current diabetes medicines and risk of low glucose?
You can also review our evidence-based overview of insulin resistance treatment and our guide to signs of high blood sugar before a visit.
When should you get help now for high glucose?
Seek urgent care now for vomiting, confusion, deep or difficult breathing, fruity breath, severe weakness, or loss of consciousness with high glucose. These symptoms can signal DKA or another serious medical problem 2.
Contact a qualified clinician soon for repeated high readings, new symptoms of diabetes, a glucose change after starting or changing a medicine, or any high glucose during pregnancy. If you have known diabetes, follow your established sick-day or emergency plan while seeking guidance from your care team 1 2.
For many nonpregnant adults without diabetes, an A1C below 5.7% is considered normal. An A1C of 5.7% to 6.4% is in the prediabetes range, and 6.5% or higher can support a diabetes diagnosis when confirmed appropriately. A clinician should interpret the result in context because some health conditions affect A1C accuracy 1.
In someone with lupus, illness, physical stress, or steroid treatment may raise glucose. A clinician can help determine whether one of these factors or another condition is contributing 3.
Family history can raise the likelihood of type 2 diabetes, and genetics also play a role in type 1 diabetes. Genes are not the only factor; environment, immune factors, body weight, and other health conditions can matter too 1.
Dehydration can occur with high glucose because frequent urination can cause fluid loss. Persistent high readings should not be dismissed as dehydration alone 3.
Statins can modestly affect glucose in some people, but they also lower cardiovascular risk for many patients. Do not stop a statin on your own; ask the prescribing clinician how the benefits and risks apply to you 7.
High glucose is an emergency when it occurs with vomiting, abdominal pain, deep or difficult breathing, fruity breath, confusion, severe drowsiness, or loss of consciousness. These can be warning signs of diabetic ketoacidosis and need urgent care 2.
Some FDA-approved GLP-1 receptor agonist products are indicated for type 2 diabetes, while other products are indicated for chronic weight management. Semaglutide and tirzepatide have different product-specific labels and risks. Compounded versions are not FDA-approved, and a clinician must determine whether any treatment is appropriate, especially for people who use insulin or sulfonylureas, are pregnant, or have pancreatitis history 4 5 11.
3-min quiz
Start with a clinician-reviewed evaluation
If persistent high glucose and weight concerns are part of the same picture, our licensed providers can review your health history online and discuss appropriate options. A prescription requires a medical evaluation and is not guaranteed. Learn about semaglutide and tirzepatide plans and current pricing. Chia medications are compounded by US state-licensed 503A pharmacies; compounded drugs are not FDA-approved 11.
References
- 1.American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care. 2025.
- 2.National Institute of Diabetes and Digestive and Kidney Diseases. Diabetic Ketoacidosis. National Institutes of Health. 2024.
- 3.Breakthrough T1D. High Blood Sugar (Hyperglycemia). Breakthrough T1D. 2026.
- 4.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2025.
- 5.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2025.
- 6.Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine. 2008.
- 7.Tarim BA, Fici F, Tengiz I, et al. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study. Yonsei Medical Journal. 2023.
- 8.Thomas F, Pretty CG, Desaive T, et al. Blood Glucose Levels of Subelite Athletes During 6 Days of Free Living. Journal of Diabetes Science and Technology. 2016.
- 9.U.S. Food and Drug Administration and Centers for Disease Control and Prevention. Preventing Infections When Monitoring Blood Glucose. MPR. 2026.
- 10.American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes—2025. Diabetes Care. 2025.
- 11.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. U.S. Food and Drug Administration. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
